Essa Pharma Inc News - EPI

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders Canada NewsWire HOUSTON and VANCOUVER, BC, Feb. 25, 2021...

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020 Canada...

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference Canada NewsWire HOUSTON and VANCOUVER, BC, Nov. 25, 2020 HOUSTON and...

ESSA Pharma Inc. Announces Delisting from the TSX-V

ESSA Pharma Inc. Announces Delisting from the TSX-V Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 26, 2020 HOUSTON and VANCOUVER, BC, Oct. 26...

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 24, 2020...

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia Canada NewsWire HOUSTON, Texas and...

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit Canada NewsWire HOUSTON and VANCOUVER, BC, Sept. 21...

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020 Canada NewsWire HOUSTON and...

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Essa Pharma Inc (EPI)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

EPI News

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

ESSA Pharma Inc. Announces Delisting from the TSX-V

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...

ESSA Pharma to Participate in Multiple Upcoming Investor Conferences

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020

ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000

L'OCRCVM permet la reprise de la négociation - EPI

IIROC Trading Resumption - EPI

EPI Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Essa Pharma Inc (EPI) News

Essa Pharma Inc (EPI)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

EPI News

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

ESSA Pharma Inc. Announces Delisting from the TSX-V

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...

ESSA Pharma to Participate in Multiple Upcoming Investor Conferences

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020

ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000

L'OCRCVM permet la reprise de la négociation - EPI

IIROC Trading Resumption - EPI

EPI Discussion

Your Recent History